One of the FOLIC ACID ANTAGONISTS that is used as an antimalarial or with a sulfonamide to treat toxoplasmosis.
A long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract, and malarial infections.
One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585)
Compounds based on 4-aminobenzenesulfonamide. The '-anil-' part of the name refers to aniline.
A sulfone active against a wide range of bacteria but mainly employed for its actions against MYCOBACTERIUM LEPRAE. Its mechanism of action is probably similar to that of the SULFONAMIDES which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with PYRIMETHAMINE in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8)
An enzyme of the oxidoreductase class that catalyzes the reaction 7,8-dihyrofolate and NADPH to yield 5,6,7,8-tetrahydrofolate and NADPH+, producing reduced folate for amino acid metabolism, purine ring synthesis, and the formation of deoxythymidine monophosphate. Methotrexate and other folic acid antagonists used as chemotherapeutic drugs act by inhibiting this enzyme. (Dorland, 27th ed) EC 1.5.1.3.
Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033)
A biguanide compound which metabolizes in the body to form cycloguanil, an anti-malaria agent.
Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture.
Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration.
A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics.
The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
An enzyme that catalyzes the formation of dihydropteroate from p-aminobenzoic acid and dihydropteridine-hydroxymethyl-pyrophosphate. EC 2.5.1.15.
Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations.
Tests that demonstrate the relative effectiveness of chemotherapeutic agents against specific parasites.
Infections of the BRAIN caused by the protozoan TOXOPLASMA gondii that primarily arise in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES (see also AIDS-RELATED OPPORTUNISTIC INFECTIONS). The infection may involve the brain diffusely or form discrete abscesses. Clinical manifestations include SEIZURES, altered mentation, headache, focal neurologic deficits, and INTRACRANIAL HYPERTENSION. (From Joynt, Clinical Neurology, 1998, Ch27, pp41-3)
Long-acting plasma-bound sulfonamide used for respiratory and urinary tract infections and also for malaria.
A hydroxynaphthoquinone that has antimicrobial activity and is being used in antimalarial protocols.
Substances that are destructive to protozoans.
A genus of protozoa parasitic to birds and mammals. T. gondii is one of the most common infectious pathogenic animal parasites of man.
A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia.
Heterocyclic rings containing three nitrogen atoms, commonly in 1,2,4 or 1,3,5 or 2,4,6 formats. Some are used as HERBICIDES.
A group of recessively inherited diseases characterized by the intralysosomal accumulation of G(M2) GANGLIOSIDE in the neuronal cells. Subtypes include mutations of enzymes in the BETA-N-ACETYLHEXOSAMINIDASES system or G(M2) ACTIVATOR PROTEIN leading to disruption of normal degradation of GANGLIOSIDES, a subclass of ACIDIC GLYCOSPHINGOLIPIDS.
Deoxyribonucleic acid that makes up the genetic material of protozoa.
A phospholipid-interacting antimalarial drug (ANTIMALARIALS). It is very effective against PLASMODIUM FALCIPARUM with very few side effects.
A group of SESQUITERPENES and their analogs that contain a peroxide group (PEROXIDES) within an oxepin ring (OXEPINS).
A republic in central Africa lying between GABON and DEMOCRATIC REPUBLIC OF THE CONGO and south of Cameroon. Its capital is Brazzaville.
Sesquiterpenes are a class of organic compounds that have a molecular formula of C15H24 and are found in various plants, with potential medicinal properties.
Acquired infection of non-human animals by organisms of the genus TOXOPLASMA.
Therapy with two or more separate preparations given for a combined effect.
A sulfanilamide that is used as an antibacterial agent.
Naphthalene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.
The acquired form of infection by Toxoplasma gondii in animals and man.
Agents useful in the treatment or prevention of COCCIDIOSIS in man or animals.
A republic in central Africa lying east of CHAD and the CENTRAL AFRICAN REPUBLIC and west of NIGERIA. The capital is Yaounde.
Inflammation of the choroid in which the sensory retina becomes edematous and opaque. The inflammatory cells and exudate may burst through the sensory retina to cloud the vitreous body.
The functional hereditary units of protozoa.
The concentration of a compound needed to reduce population growth of organisms, including eukaryotic cells, by 50% in vitro. Though often expressed to denote in vitro antibacterial activity, it is also used as a benchmark for cytotoxicity to eukaryotic cells in culture.
A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
Prenatal protozoal infection with TOXOPLASMA gondii which is associated with injury to the developing fetal nervous system. The severity of this condition is related to the stage of pregnancy during which the infection occurs; first trimester infections are associated with a greater degree of neurologic dysfunction. Clinical features include HYDROCEPHALUS; MICROCEPHALY; deafness; cerebral calcifications; SEIZURES; and psychomotor retardation. Signs of a systemic infection may also be present at birth, including fever, rash, and hepatosplenomegaly. (From Adams et al., Principles of Neurology, 6th ed, p735)
The co-occurrence of pregnancy and parasitic diseases. The parasitic infection may precede or follow FERTILIZATION.
A 4-aminoquinoline compound with anti-inflammatory properties.
A protozoan parasite that causes vivax malaria (MALARIA, VIVAX). This species is found almost everywhere malaria is endemic and is the only one that has a range extending into the temperate regions.
A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against PNEUMOCYSTIS PNEUMONIA in AIDS patients. Myelosuppression is its dose-limiting toxic effect.
An alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Quinine is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Quinine is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood.
A republic in west equatorial Africa, south of CAMEROON and west of the CONGO. Its capital is Libreville.
Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition.
Infection caused by the protozoan parasite TOXOPLASMA in which there is extensive connective tissue proliferation, the retina surrounding the lesions remains normal, and the ocular media remain clear. Chorioretinitis may be associated with all forms of toxoplasmosis, but is usually a late sequel of congenital toxoplasmosis. The severe ocular lesions in infants may lead to blindness.
An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Proteins found in any species of protozoan.
A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair.
Somalia is located on the east coast of Africa on and north of the Equator and, with Ethiopia, Eritrea, Djibouti, and Kenya, is often referred to as the Horn of Africa. It comprises Italy's former Trust Territory of Somalia and the former British Protectorate of Somaliland. The capital is Mogadishu.
The presence of parasites (especially malarial parasites) in the blood. (Dorland, 27th ed)
An enzyme of the transferase class that catalyzes the reaction 5,10-methylenetetrahydrofolate and dUMP to dihydrofolate and dTMP in the synthesis of thymidine triphosphate. (From Dorland, 27th ed) EC 2.1.1.45.
A republic in eastern Africa, south of UGANDA and north of MOZAMBIQUE. Its capital is Dar es Salaam. It was formed in 1964 by a merger of the countries of TANGANYIKA and ZANZIBAR.
A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis.
A group of Indian Ocean Islands, the islands of Great Comoro, Anjouan, Mayotte, and Moheli, lying between northeast Mozambique and northwest Madagascar. The capital is Moroni. In 1914 they became a colony attached to Madagascar administratively and were made a French overseas territory in 1947. Except for Mayotte which remained French, Comoros became an independent republic in 1975. Comoros represents the Arabic qamar, moon, said by some scholars to be linked with the mystical Mountains of the Moon said to be somewhere in equatorial Africa. (From Webster's New Geographical Dictionary, 1988, p283 & Room, Brewer's Dictionary of Names, 1992, p122)
One of the Indian Ocean Islands off the southeast coast of Africa. Its capital is Antananarivo. It was formerly called the Malagasy Republic. Discovered by the Portuguese in 1500, its history has been tied predominantly to the French, becoming a French protectorate in 1882, a French colony in 1896, and a territory within the French union in 1946. The Malagasy Republic was established in the French Community in 1958 but it achieved independence in 1960. Its name was changed to Madagascar in 1975. (From Webster's New Geographical Dictionary, 1988, p714)
This drug combination has proved to be an effective therapeutic agent with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.
A republic in western Africa, southwest of MAURITANIA and east of MALI. Its capital is Dakar.
A republic in eastern Africa, south of ETHIOPIA, west of SOMALIA with TANZANIA to its south, and coastline on the Indian Ocean. Its capital is Nairobi.
A republic in central Africa south of CHAD and SUDAN, north of DEMOCRATIC REPUBLIC OF THE CONGO, and east of CAMEROON. The capital is Bangui.
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.
Quinolines are a class of organic compounds that have been used in the medical field as antimalarial drugs and antibiotics.
A republic in southern Africa, southwest of DEMOCRATIC REPUBLIC OF THE CONGO and west of ZAMBIA. Its capital is Luanda.
Infections with species in the genus PNEUMOCYSTIS, a fungus causing interstitial plasma cell pneumonia (PNEUMONIA, PNEUMOCYSTIS) and other infections in humans and other MAMMALS. Immunocompromised patients, especially those with AIDS, are particularly susceptible to these infections. Extrapulmonary sites are rare but seen occasionally.
A country in western Africa, east of MAURITANIA and south of ALGERIA. Its capital is Bamako. From 1904-1920 it was known as Upper Senegal-Niger; prior to 1958, as French Sudan; 1958-1960 as the Sudanese Republic and 1959-1960 it joined Senegal in the Mali Federation. It became an independent republic in 1960.
A genus of ascomycetous FUNGI, family Pneumocystidaceae, order Pneumocystidales. It includes various host-specific species causing PNEUMOCYSTIS PNEUMONIA in humans and other MAMMALS.
A mammalian beta-hexosaminidase isoform that is a heteromeric protein comprized of both hexosaminidase alpha and hexosaminidase beta subunits. Deficiency of hexosaminidase A due to mutations in the gene encoding the hexosaminidase alpha subunit is a case of TAY-SACHS DISEASE. Deficiency of hexosaminidase A and HEXOSAMINIDASE B due to mutations in the gene encoding the hexosaminidase beta subunit is a case of SANDHOFF DISEASE.
Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.
A republic in western Africa, constituting an enclave within SENEGAL extending on both sides of the Gambia River. Its capital is Banjul, formerly Bathurst.
A protozoan parasite of rodents transmitted by the mosquito Anopheles dureni.
The action of a drug that may affect the activity, metabolism, or toxicity of another drug.
Detection and counting of scintillations produced in a fluorescent material by ionizing radiation.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.
A country in northeastern Africa. The capital is Khartoum.
A republic in western Africa, south of NIGER between BENIN and CAMEROON. Its capital is Abuja.
An antibacterial agent that is a semisynthetic analog of LINCOMYCIN.
A republic in western Africa, south of BURKINA FASO and west of TOGO. Its capital is Accra.
A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
A republic in southern Africa east of ZAMBIA and MOZAMBIQUE. Its capital is Lilongwe. It was formerly called Nyasaland.
Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product.
The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals.
The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS.
A family of diphenylenemethane derivatives.

Multiple mechanisms of resistance to polyglutamatable and lipophilic antifolates in mammalian cells: role of increased folylpolyglutamylation, expanded folate pools, and intralysosomal drug sequestration. (1/949)

Chinese hamster ovary PyrR100 cells display more than 1000-fold resistance to pyrimethamine (Pyr), a lipophilic antifolate inhibitor of dihydrofolate reductase. PyrR100 cells had wild-type DHFR activity, lost folate exporter activity, and had a 4-fold increased activity of a low pH folic acid transporter. Here we report on the marked alterations identified in PyrR100 cells compared with parental cells: 1) approximately 100-fold decreased folic acid growth requirement; 2) a 25-fold higher glucose growth requirement in Pyr-containing medium; 3) a 2.5- to 4.1-fold increase in folylpolyglutamate synthetase activity; 4) a 3-fold increase in the accumulation of [3H]folic acid and a 3-fold expansion of the intracellular folate pools; 5) a 4-fold increase in the activity of the lysosomal marker beta-hexoseaminidase, suggesting an increased lysosome number/PyrR100 cell; and 6) a small reduction in the steady-state accumulation of [3H]Pyr and no evidence of catabolism or modification of cellular [3H]Pyr. Consequently, PyrR100 cells were markedly resistant to the lipophilic antifolates trimetrexate (40-fold) and AG377 (30-fold) and to the polyglutamatable antifolates 5,10-Dideaza-5,6,7,8-tetrahydrofolic acid (DDATHF) (26-fold) and AG2034 (14-fold). Resistance to these drugs was reversed in PyrR100 cells transferred into folate-depleted medium. In conclusion, these multiple resistance factors collectively result in a prominent increase in folate accumulation, an expansion of the intracellular folylpolyglutamate pool, and abolishment of the cytotoxic activity of polyglutamatable and lipophilic antifolates. The role of increased lysosome number per cell in sequestration of hydrophobic weak base drugs such as Pyr is also discussed as a novel mechanism of drug resistance.  (+info)

Antimalarial activities of various 9-phenanthrenemethanols with special attention to WR-122,455 and WR-171,669. (2/949)

Pilot appraisals of the activities of 16 specially selected 9-phenanthrenemethanols against acute infections with Plasmodium falciparum in owl monkeys showed that all were more active than the reference compound, WR-33,063. WR-122,455, the most active derivative, and WR-171,669, ranked sixth, were selected for study in human volunteers. To assist this undertaking, appraisals of both compounds in owl monkeys infected with various strains of P. falciparum were expanded. These assessments showed: (i) that WR-122,455 was four times as active as chloroquine against infections with chloroquine-sensitive strains and that WR-171,669 equalled chloroquine in activity; (ii) that these compounds were fully active against infections with strains resistant to chloroquine, pyrimethamine, or quinine, or to all three standard drugs; (iii) that the activity of WR-122,455 was a function of total dose, single doses being as effective as the same amounts delivered in three or seven daily fractions; and (iv) that a single dose of WR-122,455 conferred extended, although only partial, protection against challenges with trophozoites. Complementary experiments in rhesus monkeys inoculated with sporozoites of P. cynomolgi showed that the activity of WR-122,455 was limited to blood schizonts and did not extend to early or late tissue schizonts. These evaluations were compatible with the results of preliminary studies of the activities of WR-122,455 and WR-171,669 in human volunteers.  (+info)

Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control. (3/949)

OBJECTIVES: To examine in pregnant women the relationship between HIV infection and malaria prevalence and to determine, in relation to HIV infection, the effectiveness of sulphadoxine-pyrimethamine in clearing P. falciparum infection. METHOD: Descriptive cross-sectional analysis of P. falciparum prevalence in pregnant women at first antenatal visit and of women at delivery who had received two sulphadoxine-pyrimethamine treatments for malaria. HIV status was assessed in 621 women who attended for antenatal care and for delivery at two rural hospitals in southern Malawi in 1993-94. Information was collected on maternal age, parity and gestational age. Prevalence of P. falciparum was measured at first antenatal visit and delivery. Women were given two routine treatment doses of sulphadoxine-pyrimethamine (SP), at first antenatal visit and between 28 and 34 weeks gestation, conforming to Malawi government policy on antimalarial control during pregnancy. RESULTS: Prevalence of HIV infection was 25.6% and all infections were HIV type-1. In primigravidae malaria prevalence at recruitment was 56.3% in HIV-infected and 36.5% in HIV-uninfected women (P=0.04). The corresponding figures for multigravidae were 23.8% and 11.0%, respectively (P<0.01). HIV-infected primigravidae had increased malaria prevalence at all gestational ages. Peak parasite prevalence occurred earlier in gestation in HIV-infected primigravidae (16-19 weeks if HIV-infected; 20-23 weeks if HIV-uninfected). The relative risk for parasitaemia in HIV-infected compared to HIV-uninfected women was significantly increased in three of five parity groups, including the two highest ones (parity>3), indicating parity-specific immunity to malaria was impaired. Malaria prevalence at delivery remained high in HIV-infected women despite prior routine treatment with sulphadoxine-pyrimethamine in pregnancy There was no significant difference in parasite prevalence at delivery between women who did or did not use sulphadoxine-pyrimethamine. CONCLUSIONS: HIV infection is associated with a significant increase in malaria prevalence in pregnant women of all parities with the effect apparent from early in gestation. Two treatment doses of sulphadoxine-pyrimethamine were inadequate to clear parasitaemia in many women by the time of delivery and this occurred independently of HIV status and despite high sensitivity to SP in this area. There is a need to undertake longitudinal studies to determine the incidence of P. falciparum infection in HIV-infected and uninfected pregnant women and to reassess the frequency and timing of sulphadoxine-pyrimethamine treatment doses in these women. Late pregnancy re-infections with P. falciparum probably explain the high parasite prevalence at delivery following sulphadoxine-pyrimethamine treatment at 28-34 weeks gestation.  (+info)

Response of falciparum malaria to different antimalarials in Myanmar. (4/949)

The purpose of the study was to ascertain the therapeutic efficacy of different treatments for uncomplicated falciparum malaria in the hospitals in Sagaing, northern and eastern Shan, to facilitate updating the existing national antimalarial drug policy. The proposed 14-day trial for monitoring the efficacy of treatments of uncomplicated falciparum malaria is an efficient method for identifying treatment failure patterns at the intermediate level (township hospital) in the Union of Myanmar. Minimal clinical and parasitological data for days 0-14 were required to classify treatment failure and success. Clinical and parasitiological responses on day 3 and days 4-14 were used as clear examples of early and late treatment failure, respectively. Mefloquine is five times more likely to be effective than chloroquine and sulfadoxine pyrimethamine (S-P), whereas chloroquine and S-P treatments have nearly identical failure patterns. The alarming frequency of clinical and parasitological failure (failure rate > 50%) following chloroquine treatment was reported in Sagaing and following S-P treatment in Sagaing and eastern Shan.  (+info)

Green fluorescent protein as a marker in Plasmodium berghei transformation. (5/949)

We present a new marker that confers both resistance to pyrimethamine and green fluorescent protein-based fluorescence on the malarial parasite Plasmodium berghei. A single copy of the cassette integrated into the genome is sufficient to direct fluorescence in parasites throughout the life cycle, in both its mosquito and vertebrate hosts. Erythrocyte stages of the parasite that express the marker can be sorted from control parasites by flow cytometry. Pyrimethamine pressure is not necessary for maintaining the cassette in transformed parasites during their sporogonic cycle in mosquitoes, including when it is borne by a plasmid. This tool should thus prove useful in molecular studies of P. berghei, both for generating parasite variants and monitoring their behavior.  (+info)

Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines. (6/949)

This randomized, open-label clinical trial compared a fixed-dose combination of atovaquone and proguanil (n=55) with chloroquine (n=23) or a combination of chloroquine, sulfadoxine, and pyrimethamine (n=32) for treatment of acute falciparum malaria in the Philippines. Patients were hospitalized for 28 days to ensure medication compliance and prevent reinfection. Atovaquone-proguanil produced a significantly higher cure rate (100%) compared with that for chloroquine (30.4%; P<.0001) or chloroquine-sulfadoxine-pyrimethamine (87.5%; P<.05). Treatments did not differ significantly with respect to parasite clearance time (mean: 46.7 h for atovaquone-proguanil, 60.0 h for chloroquine, and 42.8 h for chloroquine-sulfadoxine-pyrimethamine) or fever clearance time (mean, 38.8, 46.8, and 34.5 h, respectively). Adverse events were typical of malaria symptoms; the most frequently reported events were vomiting (18% for atovaquone-proguanil, 17% for chloroquine, and 9% for chloroquine-sulfadoxine-pyrimethamine), abdominal pain (15%, 17%, and 3%, respectively), anorexia (11%, 13%, and 0%, respectively), and headache (6%, 17%, and 3%, respectively). Atovaquone-proguanil was well tolerated and more effective than chloroquine or chloroquine-sulfadoxine-pyrimethamine for treatment of multidrug-resistant falciparum malaria in the Philippines.  (+info)

In vivo responses to antimalarials by Plasmodium falciparum and Plasmodium vivax from isolated Gag Island off northwest Irian Jaya, Indonesia. (7/949)

There is renewed interest in the rich nickel and cobalt deposits of Pulau Gag, an isolated but malarious island off the northwest coast of Irian Jaya. In preparation for an expanded workforce, an environmental assessment of malaria risk was made, focusing upon malaria prevalence in the small indigenous population, and the in vivo sensitivity of Plasmodium falciparum and P. vivax to chloroquine (CQ) and sulfadoxine/pyrimethamine (S/P), the respective first- and second-line drugs for uncomplicated malaria in Indonesia. During April-June 1997, mildly symptomatic or asymptomatic malaria infections were found in 24% of 456 native residents. Infections by P. falciparum accounted for 60% of the cases. Respective day 28 cure rates for CQ (10 mg base/kg on days 0 and 1; 5 mg/kg on day 2) in children and adults were 14% and 55% (P < 0.005). Type RII and RIII resistance characterized only 5% of the CQ failures. Re-treatment of 36 P. falciparum CQ treatment failures with S/P (25 mg/kg and 1.25 mg/kg, respectively) demonstrated rapid clearance and complete sensitivity during the 28-day follow-up period. More than 97% of the P. vivax malaria cases treated with CQ cleared parasitemia within 48 hr. Three cases of P. vivax malaria recurred between days 21 and 28, but against low drug levels in the blood. The low frequency of RII and RIII P. falciparum resistance to CQ, the complete sensitivity of this species to S/P, and the absence of CQ resistance by P. vivax are in contrast to in vivo and in vitro test results from sites on mainland Irian Jaya.  (+info)

Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. (8/949)

OBJECTIVE: To summarise the evidence that treating toxoplasmosis in pregnancy reduces the risk of congenital toxoplasma infection and improves infant outcomes. DESIGN: Systematic review of studies comparing at least two concurrent groups of pregnant women with proved or likely acute toxoplasma infection in which treatments were compared with no treatment and outcomes in the children were reported. SUBJECTS: Studies were identified from Medline (1966-97), Pascal (1990-7), Embase (1993-7), and Biological abstracts (1993-5) plus contact with experts in the field, including the European Research Network on Congenital Toxoplasmosis. MAIN OUTCOME MEASURE: Proportion of infected children at 1 year born to infected pregnant women who were or were not treated. RESULTS: Out of 2591 papers identified, nine met the inclusion criteria. There were no randomised comparisons, and control groups were generally not directly comparable with the treatment groups. Congenital infection was common in treated groups. five studies showed that treatment was effective and four that it was not. CONCLUSION: It is unclear whether antenatal treatment in women with presumed toxoplasmosis reduces congenital transmission of Toxoplasma gondii. Screening is expensive, so the effects of treatment and impact of screening programmes need to be evaluated. In countries where screening or treatment is not routine, these technologies should not be introduced outside carefully controlled trials.  (+info)

Pyrimethamine is an antiparasitic medication that is used to treat certain types of parasitic infections, including malaria caused by Plasmodium falciparum and vivax. It works by inhibiting the growth and reproduction of the parasites in the body. Pyrimethamine is usually given in combination with other antimalarial drugs, such as sulfadoxine-pyrimethamine (Fansidar), to increase its effectiveness and reduce the risk of resistance. It is usually taken orally as a tablet or capsule. Common side effects of pyrimethamine include nausea, vomiting, loss of appetite, and headache. In rare cases, it can cause more serious side effects, such as anemia, liver damage, and allergic reactions. Pyrimethamine is contraindicated in patients with a history of hypersensitivity to the drug or any of its components, as well as in patients with severe liver or kidney disease. It should also be used with caution in pregnant women and breastfeeding mothers, as it may harm the developing fetus or newborn.

Sulfadoxine is an antiparasitic medication that is used to treat a variety of parasitic infections, including malaria, schistosomiasis, and toxoplasmosis. It works by inhibiting the growth and reproduction of parasites in the body. Sulfadoxine is often used in combination with other antiparasitic medications to increase its effectiveness and reduce the risk of resistance. It is usually taken orally in the form of tablets or capsules. Side effects of sulfadoxine may include nausea, vomiting, headache, and dizziness. It is important to follow the instructions of a healthcare provider when taking sulfadoxine and to complete the full course of treatment, even if symptoms improve before the medication is finished.

Sulfadiazine is an antibiotic medication that is used to treat a variety of bacterial infections, including urinary tract infections, skin infections, and respiratory infections. It works by inhibiting the growth and reproduction of bacteria in the body. Sulfadiazine is typically administered orally in the form of tablets or capsules. It may also be available as a liquid or as a cream or ointment for topical use. It is important to note that sulfadiazine is not effective against viral infections, such as the flu or common cold. It is also not recommended for use in pregnant women or children under the age of 12, as it may cause harm to these populations. Side effects of sulfadiazine may include nausea, vomiting, diarrhea, headache, and skin rash. In rare cases, it may cause more serious side effects, such as liver damage or blood disorders. It is important to follow the instructions of your healthcare provider and to report any side effects to them immediately.

Sulfanilamides are a group of synthetic antimicrobial drugs that were first developed in the early 20th century. They are also known as sulfa drugs or sulphonamides. Sulfanilamides work by inhibiting the growth of bacteria by interfering with their ability to synthesize folic acid, which is essential for their growth and reproduction. Sulfanilamides are commonly used to treat a variety of bacterial infections, including urinary tract infections, bronchitis, and pneumonia. They are also used to treat some skin infections, such as acne and rosacea. However, sulfanilamides are not effective against viral infections or fungal infections. They can also cause side effects, such as nausea, vomiting, and allergic reactions. In some cases, sulfanilamides can cause more serious side effects, such as anemia, liver damage, and blood disorders. Sulfanilamides are no longer the first-line treatment for many bacterial infections, as newer antibiotics have been developed that are more effective and have fewer side effects. However, they are still used in some cases, particularly in developing countries where access to newer antibiotics may be limited.

Dapsone is a medication that is used to treat a variety of infections, including leprosy, dermatitis herpetiformis, and certain types of pneumonia. It is also used to treat certain types of parasitic infections, such as babesiosis and trypanosomiasis. Dapsone works by inhibiting the production of folic acid, which is essential for the growth and reproduction of bacteria and parasites. It is usually taken by mouth, although it can also be given intravenously or topically. Side effects of dapsone may include nausea, vomiting, headache, and anemia. It is important to note that dapsone can cause a severe reaction called Steven-Johnson syndrome, which can be life-threatening. Therefore, it should only be used under the supervision of a healthcare professional.

Tetrahydrofolate dehydrogenase (THD) is an enzyme that plays a crucial role in the metabolism of folate, a B-vitamin that is essential for the synthesis of DNA, RNA, and amino acids. THD catalyzes the conversion of tetrahydrofolate (THF) to dihydrofolate (DHF), which is a key intermediate in the one-carbon transfer reactions that are necessary for the biosynthesis of nucleotides and amino acids. In the medical field, THD deficiency can lead to a range of health problems, including anemia, megaloblastic anemia, and neural tube defects. THD deficiency can be caused by genetic mutations that affect the enzyme's structure or function, or by nutritional deficiencies of folate or its precursors. Treatment for THD deficiency typically involves supplementation with folate or its precursors, as well as management of any underlying medical conditions.

Proguanil is an antimalarial medication that is used to prevent and treat certain types of malaria. It works by inhibiting the growth and reproduction of the Plasmodium parasite, which causes malaria. Proguanil is typically taken as a pill and is often used in combination with other antimalarial medications to increase its effectiveness. It is usually prescribed for travelers to areas where malaria is common, as well as for people who are at high risk of contracting the disease due to their occupation or health status.

Chloroquine is an antimalarial drug that was first discovered in the 1930s. It is a synthetic derivative of quinine, a natural alkaloid found in the bark of the cinchona tree. Chloroquine is used to treat and prevent malaria caused by Plasmodium falciparum, Plasmodium vivax, and other species of Plasmodium. Chloroquine works by inhibiting the growth and reproduction of the Plasmodium parasite within red blood cells. It does this by interfering with the parasite's ability to synthesize heme, a vital component of hemoglobin, which is necessary for the survival of the parasite. Chloroquine is also used to treat autoimmune diseases such as rheumatoid arthritis and lupus. It works by suppressing the immune system's response to foreign substances, reducing inflammation and pain. Chloroquine is available in tablet form and is usually taken orally. It can cause side effects such as nausea, vomiting, headache, and dizziness. Long-term use of chloroquine can also cause retinopathy, a condition that affects the eyes and can lead to vision loss.

Dihydropteroate synthase (DHPS) is an enzyme that plays a crucial role in the biosynthesis of folic acid, a vital nutrient required for the proper functioning of the human body. DHPS catalyzes the conversion of dihydropteroate to 6-hydroxymethyl-7,8-dihydropteroyl-L-glutamate, which is a key intermediate in the synthesis of folic acid. DHPS is a target for the development of antifolate drugs, which are used to treat a variety of infectious and neoplastic diseases. Inhibition of DHPS can lead to a deficiency of folic acid, which can cause a range of symptoms including anemia, megaloblastic anemia, and neural tube defects in developing fetuses. DHPS is found in a variety of organisms, including bacteria, fungi, and plants, and is a target for the development of antibiotics and herbicides. In humans, DHPS is encoded by the DHPS gene, which is located on chromosome 12.

Malaria, Falciparum is a type of malaria caused by the Plasmodium falciparum parasite. It is the most deadly form of malaria, accounting for the majority of malaria-related deaths worldwide. The parasite is transmitted to humans through the bite of infected female Anopheles mosquitoes. Symptoms of falciparum malaria can include fever, chills, headache, muscle and joint pain, nausea, vomiting, and fatigue. In severe cases, the disease can lead to organ failure, coma, and death. Falciparum malaria is typically treated with antimalarial drugs, such as artemisinin-based combination therapies (ACTs). Prevention measures include the use of insecticide-treated bed nets, indoor residual spraying, and antimalarial prophylaxis for travelers to high-risk areas.

Toxoplasmosis, cerebral refers to an infection of the brain caused by the protozoan parasite Toxoplasma gondii. The parasite can infect people and animals, and it is commonly found in cats. When the parasite infects the brain, it can cause inflammation and damage to brain tissue, leading to a range of symptoms such as headaches, fever, confusion, seizures, and changes in behavior or personality. In severe cases, cerebral toxoplasmosis can be life-threatening. It is typically diagnosed through blood tests or imaging studies such as MRI or CT scans. Treatment may involve antiparasitic medications to kill the parasite and reduce inflammation in the brain.

Sulfalene is a medication that is used to treat bacterial infections, including urinary tract infections, skin infections, and respiratory tract infections. It is a type of antibiotic that works by killing or stopping the growth of bacteria. Sulfalene is available in both oral and topical forms, and it is usually taken for a short period of time, typically 7 to 14 days. It is important to follow the instructions of your healthcare provider when taking sulfalene, as taking too much or not taking it at all can lead to antibiotic resistance and other complications.

Atovaquone is an antiprotozoal medication that is used to treat certain types of parasitic infections, including malaria caused by Plasmodium falciparum and P. vivax. It is also used to treat babesiosis, a tick-borne infection caused by the parasite Babesia microti. Atovaquone works by inhibiting the growth and reproduction of the parasites in the body. It is usually taken orally in the form of tablets or capsules.

Malaria is a mosquito-borne infectious disease caused by Plasmodium parasites. It is characterized by fever, chills, headache, muscle aches, and fatigue. In severe cases, it can lead to anemia, respiratory distress, organ failure, and death. Malaria is primarily found in tropical and subtropical regions, particularly in Africa, Asia, and Latin America. There are four main species of Plasmodium that can cause malaria in humans: P. falciparum, P. vivax, P. ovale, and P. malariae. Malaria is preventable and treatable, but,。

Triazines are a class of organic compounds that contain a three-membered nitrogen ring. They are commonly used as herbicides, pesticides, and fungicides. In the medical field, triazines have been studied for their potential use in the treatment of various conditions, including cancer, viral infections, and inflammatory diseases. Some specific examples of triazines that have been studied for medical use include protriptyline, a tricyclic antidepressant, and terbinafine, an antifungal medication. However, it is important to note that the use of triazines in medicine is still in the experimental stage, and more research is needed to fully understand their potential therapeutic benefits and risks.

Gangliosidoses, GM2 is a group of rare genetic disorders that affect the nervous system. These disorders are caused by a deficiency or absence of an enzyme called beta-hexosaminidase A, which is responsible for breaking down a type of fat molecule called ganglioside GM2. As a result, GM2 builds up in the brain and other parts of the body, leading to a range of symptoms and complications. There are two main types of GM2 gangliosidoses: Tay-Sachs disease and Sandhoff disease. Tay-Sachs disease is the more severe form of the disorder and typically affects infants and young children. Symptoms of Tay-Sachs disease can include developmental delays, muscle weakness, vision and hearing loss, and an enlarged liver and spleen. Sandhoff disease is a less severe form of the disorder that typically affects children and adolescents, and symptoms can include developmental delays, muscle weakness, and vision and hearing loss. There is currently no cure for GM2 gangliosidoses, and treatment is focused on managing symptoms and providing supportive care. This may include physical therapy, occupational therapy, and medications to manage seizures and other symptoms. In some cases, bone marrow transplantation may be considered as a potential treatment option.

DNA, Protozoan refers to the genetic material of protozoans, which are single-celled organisms that belong to the kingdom Protista. Protozoans are a diverse group of organisms that can be found in a variety of environments, including soil, water, and the human body. Protozoans have their own unique DNA, which contains the genetic information necessary for their growth, development, and reproduction. This DNA is organized into chromosomes, which are structures that contain the genetic material of an organism. In the medical field, knowledge of the DNA of protozoans is important for understanding the biology of these organisms and for developing treatments for infections caused by protozoans. For example, the DNA of the protozoan Plasmodium, which causes malaria, has been extensively studied in order to develop drugs and vaccines to treat and prevent this disease.

Mefloquine is an antimalarial medication that is used to prevent and treat malaria caused by Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, and Plasmodium malariae. It is also used to treat certain types of amebiasis, a parasitic infection caused by the amoeba Entamoeba histolytica. Mefloquine is taken orally and works by inhibiting the growth and reproduction of the parasites that cause these infections. It is a member of a class of drugs called quinolines, which are synthetic compounds that have antimalarial activity. Mefloquine is generally well-tolerated, but it can cause side effects such as headache, nausea, dizziness, and insomnia. It is important to take mefloquine exactly as prescribed by a healthcare provider to ensure its effectiveness and to minimize the risk of side effects.

Artemisinins are a group of naturally occurring compounds derived from the plant Artemisia annua, also known as sweet wormwood. They have been used for centuries in traditional medicine to treat a variety of ailments, including fever, malaria, and other infections. In the medical field, artemisinins are primarily used to treat malaria, a life-threatening disease caused by Plasmodium parasites. Artemisinin-based combination therapies (ACTs) are the most effective and widely used treatments for malaria, and they have been credited with saving millions of lives since their introduction in the 1990s. Artemisinins are also being studied for their potential use in treating other diseases, including cancer, bacterial infections, and viral infections such as HIV and Ebola. However, more research is needed to fully understand their mechanisms of action and potential therapeutic applications.

Sesquiterpenes are a class of organic compounds that are derived from terpenes, which are a large and diverse group of natural compounds found in plants, fungi, and some bacteria. Sesquiterpenes are characterized by their molecular formula, which contains 15 carbon atoms arranged in a specific pattern. In the medical field, sesquiterpenes have been studied for their potential therapeutic properties. Some sesquiterpenes have been found to have anti-inflammatory, anti-cancer, and anti-viral effects. For example, some sesquiterpenes have been shown to inhibit the growth of cancer cells and to reduce inflammation in the body. Sesquiterpenes are also used in traditional medicine and are found in a variety of plants, including chamomile, sage, and valerian. Some sesquiterpenes have been used to treat a variety of conditions, including anxiety, insomnia, and digestive disorders. Overall, sesquiterpenes are a promising class of compounds with potential therapeutic applications in the medical field. However, more research is needed to fully understand their properties and potential uses.

Toxoplasmosis, Animal refers to a parasitic infection caused by the protozoan parasite Toxoplasma gondii, which is commonly found in cats and other animals. The infection can be transmitted to humans through contact with infected animal feces, ingestion of undercooked meat containing the parasite, or congenital transmission from an infected mother to her fetus. In animals, the infection can cause a range of clinical signs, including fever, anorexia, and weight loss. However, many animals are asymptomatic carriers of the parasite. In severe cases, the infection can lead to neurological and ocular complications. Treatment for toxoplasmosis in animals typically involves the use of anti-parasitic medications.

Sulfamerazine is an antibiotic medication that is used to treat a variety of bacterial infections, including urinary tract infections, skin infections, and respiratory infections. It is a member of the sulfonamide class of antibiotics, which work by inhibiting the growth of bacteria by interfering with their ability to synthesize folic acid, an essential nutrient for bacterial growth. Sulfamerazine is available in both oral and topical forms, and is typically prescribed by a healthcare provider to treat specific bacterial infections. It is important to follow the dosing instructions provided by your healthcare provider and to complete the full course of treatment, even if you start to feel better before the medication is finished.

Naphthoquinones are a class of organic compounds that contain a naphthalene ring with a quinone group. They are commonly found in plants and have a wide range of biological activities, including antioxidant, anti-inflammatory, and anticancer properties. In the medical field, naphthoquinones are being studied for their potential use in the treatment of various diseases, such as cancer, cardiovascular disease, and infectious diseases. Some naphthoquinones, such as plumbagin and lawsone, have shown promising results in preclinical studies and are being investigated for their therapeutic potential. However, more research is needed to fully understand the safety and efficacy of naphthoquinones as a treatment for human diseases.

Toxoplasmosis is a parasitic infection caused by the protozoan parasite Toxoplasma gondii. It can affect humans and other animals, including cats, dogs, birds, and rodents. The infection is typically acquired by ingesting food or water contaminated with the parasite, or by coming into contact with infected cat feces. In most healthy individuals, the infection is asymptomatic and clears on its own within a few weeks to a few months. However, in pregnant women, the infection can be transmitted to the developing fetus and cause serious complications such as miscarriage, stillbirth, or birth defects. In people with weakened immune systems, such as those with HIV/AIDS or organ transplant recipients, the infection can cause more severe symptoms and complications. Toxoplasmosis can be diagnosed through blood tests or imaging studies such as ultrasounds or MRIs. Treatment with antiparasitic medications is typically recommended for pregnant women and people with weakened immune systems to prevent complications.

Chorioretinitis is an inflammation of the choroid and retina, which are two layers of tissue at the back of the eye. It can be caused by a variety of factors, including infections, autoimmune diseases, and certain medications. Symptoms of chorioretinitis may include blurred vision, sensitivity to light, and floaters (spots or specks that appear in the field of vision). Treatment for chorioretinitis depends on the underlying cause and may include medications, laser therapy, or surgery.,chorioretinitis。

Trimethoprim is an antibiotic medication that is commonly used to treat bacterial infections, particularly those caused by the bacteria Pneumocystis jirovecii, which can cause pneumonia in people with weakened immune systems, such as those with HIV/AIDS. Trimethoprim is also used to treat urinary tract infections, ear infections, and other types of bacterial infections. It works by inhibiting the growth of bacteria by blocking the production of folic acid, which is essential for the growth and reproduction of bacteria. Trimethoprim is available in both oral and intravenous forms and is usually taken for a period of 7 to 14 days, depending on the type and severity of the infection.

Toxoplasmosis, congenital refers to the transmission of the protozoan parasite Toxoplasma gondii from an infected mother to her fetus during pregnancy. The infection can cause serious health problems in the developing fetus, including brain damage, vision loss, and hearing loss. It is estimated that up to one in every 100 babies born in the United States each year are affected by congenital toxoplasmosis. The infection can be prevented by avoiding exposure to the parasite, such as by washing hands thoroughly after handling raw meat or soil, and by avoiding contact with cat feces. If a woman is infected with T. gondii during pregnancy, her healthcare provider may prescribe medication to reduce the risk of transmission to the fetus.

Pregnancy complications related to parasites refer to health problems that occur during pregnancy as a result of infections caused by parasites. These infections can be transmitted from the mother to the fetus, leading to complications for both the mother and the baby. Some common parasites that can cause pregnancy complications include: 1. Toxoplasmosis: This is caused by the parasite Toxoplasma gondii and can be transmitted to the fetus through the placenta. It can cause miscarriage, stillbirth, or birth defects such as hydrocephalus, brain damage, and vision problems. 2. Malaria: This is caused by the Plasmodium parasite and is transmitted through the bite of an infected mosquito. It can cause anemia, low birth weight, and preterm birth. 3. Chagas disease: This is caused by the Trypanosoma cruzi parasite and is transmitted through the feces of infected triatomine bugs. It can cause miscarriage, stillbirth, and birth defects such as heart problems. 4. Schistosomiasis: This is caused by the Schistosoma parasite and is transmitted through contact with contaminated water. It can cause anemia, low birth weight, and preterm birth. 5. Leishmaniasis: This is caused by the Leishmania parasite and is transmitted through the bite of an infected sandfly. It can cause miscarriage, stillbirth, and birth defects such as hydrocephalus. Prompt diagnosis and treatment of these infections are crucial to prevent complications for both the mother and the baby.

Amodiaquine is an antimalarial medication that is used to treat and prevent malaria caused by Plasmodium falciparum and Plasmodium vivax. It is a member of the 8-aminoquinoline class of antimalarial drugs and works by inhibiting the growth and reproduction of the malaria parasite within red blood cells. Amodiaquine is typically used in combination with other antimalarial drugs, such as artemisinin-based combination therapies (ACTs), to increase its effectiveness and reduce the risk of resistance. It is usually taken orally as a tablet or as a liquid suspension. Common side effects of amodiaquine include nausea, vomiting, headache, dizziness, and skin rash. In rare cases, it can cause more serious side effects, such as liver damage or allergic reactions. Amodiaquine is contraindicated in patients with known hypersensitivity to the drug or to any of its components, as well as in patients with severe liver or kidney disease. It should also be used with caution in patients with a history of epilepsy or other neurological disorders.

Trimetrexate is a medication that is used to treat certain types of infections caused by bacteria, fungi, and parasites. It is a member of a class of drugs called trimethoprim-sulfonamides, which work by inhibiting the growth and reproduction of these microorganisms. Trimetrexate is typically used to treat infections of the skin, respiratory tract, and urinary tract. It may also be used to treat certain types of parasitic infections, such as giardiasis and toxoplasmosis. Trimetrexate is usually taken by mouth in the form of tablets or capsules. The dosage and duration of treatment will depend on the specific infection being treated and the patient's overall health. It is important to follow the instructions provided by your healthcare provider and to complete the full course of treatment, even if you start to feel better before the medication is finished. Like all medications, trimetrexate can cause side effects. Common side effects may include nausea, vomiting, diarrhea, and headache. More serious side effects may include allergic reactions, liver damage, and bone marrow suppression. If you experience any side effects while taking trimetrexate, you should contact your healthcare provider right away.

Quinine is a medication that is used to treat and prevent certain types of malaria. It works by interfering with the growth and reproduction of the parasites that cause malaria. Quinine is also sometimes used to treat leg cramps and to prevent or treat altitude sickness. It is usually taken as an oral tablet or as an intravenous infusion. Quinine can cause side effects such as nausea, vomiting, headache, and ringing in the ears. It can also interact with other medications, so it is important to tell your doctor about all the medications you are taking before starting quinine.

Encephalitis is a medical condition characterized by inflammation of the brain. It can be caused by a variety of factors, including viral or bacterial infections, autoimmune disorders, or exposure to certain toxins. Symptoms of encephalitis can vary widely and may include fever, headache, confusion, seizures, and changes in behavior or personality. In severe cases, encephalitis can lead to long-term neurological damage or even death. Treatment for encephalitis typically involves addressing the underlying cause of the inflammation and providing supportive care to manage symptoms and prevent complications.

Toxoplasmosis, ocular refers to an infection of the eyes caused by the protozoan parasite Toxoplasma gondii. This infection can occur in people who have never had the infection before, as well as in those who have previously been infected with the parasite. The most common way that people become infected with T. gondii is by ingesting the parasite through contaminated food or water, or by coming into contact with infected cat feces. Once the parasite enters the body, it can travel to the eyes and cause inflammation and damage to the retina, which can lead to vision problems or even blindness. Symptoms of ocular toxoplasmosis may include blurred vision, sensitivity to light, and floaters (spots or specks that appear in the field of vision). In some cases, the infection may be asymptomatic and not cause any noticeable symptoms. Treatment for ocular toxoplasmosis typically involves the use of antiparasitic medications, such as pyrimethamine and sulfadiazine, to eliminate the infection and prevent further damage to the eyes. In some cases, surgery may be necessary to repair damage to the retina or to remove scar tissue that has formed as a result of the infection.

Primaquine is an antimalarial medication that is used to treat and prevent certain types of malaria. It is a synthetic derivative of quinine, which is a natural alkaloid found in the bark of the cinchona tree. Primaquine works by inhibiting the growth and reproduction of the Plasmodium parasite, which causes malaria. It is typically used in combination with other antimalarial medications, such as chloroquine or artemisinin-based combination therapies (ACTs), to increase its effectiveness and reduce the risk of resistance. Primaquine is available in both oral and intravenous forms and is usually taken once or twice a day for several weeks. It is generally well-tolerated, but it can cause side effects such as nausea, vomiting, and anemia in some people.

Sulfinpyrazone is a medication that is used to treat gout, a type of arthritis that is caused by the buildup of uric acid crystals in the joints. It works by reducing the amount of uric acid that is produced by the body, which helps to prevent the formation of uric acid crystals and reduce the frequency and severity of gout attacks. It is usually taken in combination with other medications, such as allopurinol, to help lower uric acid levels in the blood.

Protozoan proteins are proteins that are produced by protozoa, which are single-celled organisms that belong to the kingdom Protista. Protozoa are found in a wide range of environments, including soil, water, and the bodies of animals and humans. Protozoan proteins can be of interest in the medical field because some protozoa are pathogenic, meaning they can cause disease in humans and other animals. For example, the protozoan parasite Trypanosoma brucei, which causes African sleeping sickness, produces a number of proteins that are important for its survival and replication within the host organism. Protozoan proteins can also be studied as potential targets for the development of new drugs to treat protozoan infections. For example, researchers are exploring the use of antibodies that target specific protozoan proteins to prevent or treat diseases caused by these organisms. In addition to their potential medical applications, protozoan proteins are also of interest to researchers studying the evolution and biology of these organisms. By studying the proteins produced by protozoa, scientists can gain insights into the genetic and biochemical mechanisms that underlie the biology of these organisms.

Parasitemia is a medical term used to describe the presence of parasites in the blood of an infected individual. It refers to the number of parasites present in a unit volume of blood, usually expressed as the number of parasites per microliter (µL) of blood. Parasitemia is commonly used to monitor the severity of infections caused by parasites such as malaria, leishmaniasis, and trypanosomiasis. The level of parasitemia can also be used to determine the appropriate treatment for the infection. In some cases, high levels of parasitemia can lead to severe symptoms and complications, such as anemia, organ damage, and even death. Therefore, monitoring parasitemia is an important part of the diagnosis and management of parasitic infections.

Thymidylate synthase (TS) is an enzyme that plays a crucial role in DNA synthesis. It catalyzes the conversion of deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), which is a key intermediate in the synthesis of DNA. In the medical field, TS is an important target for cancer chemotherapy. Many anticancer drugs, such as 5-fluorouracil (5-FU) and methotrexate, work by inhibiting TS, thereby blocking DNA synthesis and leading to cell death. Mutations in the TS gene can also lead to inherited disorders such as thymidylate synthase deficiency, which is a rare autosomal recessive disorder characterized by severe combined immunodeficiency and bone marrow failure.

Pneumonia, Pneumocystis is a type of pneumonia caused by the Pneumocystis jirovecii fungus. It is a common infection in people with weakened immune systems, such as those with HIV/AIDS, organ transplant recipients, and patients undergoing chemotherapy or radiation therapy. The symptoms of Pneumocystis pneumonia can include fever, cough, shortness of breath, chest pain, and fatigue. In severe cases, it can lead to respiratory failure and death if left untreated. Diagnosis of Pneumocystis pneumonia typically involves a combination of chest X-rays, blood tests, and microscopic examination of sputum or bronchoalveolar lavage fluid. Treatment typically involves the use of antifungal medications, such as trimethoprim-sulfamethoxazole or pentamidine.

Trimethoprim-Sulfamethoxazole Combination is a medication that contains two antibiotics: trimethoprim and sulfamethoxazole. It is commonly used to treat bacterial infections such as urinary tract infections, respiratory tract infections, and skin infections. The combination of these two antibiotics provides a broad spectrum of coverage against a variety of bacteria. Trimethoprim inhibits bacterial dihydrofolate reductase, while sulfamethoxazole inhibits bacterial dihydropteroate synthase, both of which are essential for bacterial growth and replication. The medication is usually taken orally in tablet form and is generally well-tolerated, although it may cause side effects such as nausea, vomiting, and allergic reactions.

Quinolines are a class of organic compounds that have a fused ring system consisting of a six-membered aromatic ring and a five-membered heterocyclic ring containing nitrogen. They are structurally related to quinine, which is a well-known antimalarial drug. In the medical field, quinolines have been studied for their potential therapeutic applications in various diseases. Some of the most notable examples include: 1. Antimalarial activity: Quinolines have been used as antimalarial drugs for many years, with quinine being the most widely used. However, resistance to quinine has emerged in some regions, leading to the development of new quinoline-based drugs, such as chloroquine and artemisinin. 2. Antibacterial activity: Some quinolines have been found to have antibacterial activity against a range of gram-positive and gram-negative bacteria. For example, nalidixic acid is a quinoline antibiotic used to treat urinary tract infections caused by certain bacteria. 3. Antiviral activity: Quinolines have also been studied for their potential antiviral activity against viruses such as influenza, HIV, and herpes simplex virus. 4. Antifungal activity: Some quinolines have been found to have antifungal activity against Candida species, which are common causes of fungal infections in humans. Overall, quinolines have a diverse range of potential therapeutic applications in the medical field, and ongoing research is exploring their use in the treatment of various diseases.

Pneumocystis infections are a group of respiratory infections caused by the fungus Pneumocystis jirovecii. These infections are most commonly seen in people with weakened immune systems, such as those with HIV/AIDS, organ transplant recipients, and patients undergoing chemotherapy or radiation therapy. Pneumocystis infections can range from mild to severe and can cause symptoms such as cough, shortness of breath, fever, and fatigue. In severe cases, the infection can lead to pneumonia, which can be life-threatening. Diagnosis of Pneumocystis infections typically involves a combination of clinical symptoms, imaging studies, and laboratory tests. Treatment typically involves the use of antifungal medications, such as trimethoprim-sulfamethoxazole or pentamidine. Pneumocystis infections are a significant public health concern, particularly in populations with weakened immune systems. Efforts to prevent the spread of the fungus include vaccination, infection control measures, and the use of antifungal prophylaxis in high-risk populations.

Hexosaminidase A is an enzyme that plays a crucial role in the breakdown of certain complex sugars, known as gangliosides, which are found in the brain and other parts of the nervous system. Gangliosides are important for the proper functioning of nerve cells, and hexosaminidase A helps to break them down into simpler sugars that can be used by the body for energy. Mutations in the gene that codes for hexosaminidase A can lead to a group of inherited disorders known as lysosomal storage diseases, which are characterized by the accumulation of undigested gangliosides in the body's cells. The most common of these disorders is Tay-Sachs disease, which affects primarily infants and young children and is caused by a deficiency in hexosaminidase A. Other lysosomal storage diseases that are caused by mutations in the hexosaminidase A gene include Sandhoff disease and GM2 gangliosidosis. Hexosaminidase A is also important for the breakdown of certain types of bacteria and viruses, and it has been studied as a potential target for the development of new treatments for infectious diseases.

AIDS-Related Opportunistic Infections (AROIs) are infections that occur when the immune system is weakened due to HIV/AIDS. The immune system is responsible for fighting off infections and diseases, but when it is weakened, it is unable to effectively fight off these infections. As a result, people with HIV/AIDS are more susceptible to a variety of infections that would not normally cause illness in people with a healthy immune system. These infections are called opportunistic infections because they take advantage of the weakened immune system to cause illness. Some common AROIs include pneumonia, tuberculosis, and yeast infections. Treatment for AROIs typically involves antiretroviral therapy (ART) to control the HIV infection and medications to treat the specific infection.

Clindamycin is an antibiotic medication that is used to treat a variety of bacterial infections. It is a lincosamide antibiotic that works by stopping the growth of bacteria. Clindamycin is often used to treat infections of the skin, respiratory tract, and reproductive system, as well as certain types of bacterial infections that are resistant to other antibiotics. It is usually taken by mouth or given by injection, depending on the type and severity of the infection being treated. Clindamycin can cause side effects such as nausea, diarrhea, and stomach pain, and it may interact with other medications, so it is important to follow your healthcare provider's instructions carefully when taking this medication.

Sulfamethoxazole is an antibiotic medication that is used to treat a variety of bacterial infections, including urinary tract infections, respiratory infections, skin infections, and ear infections. It is a member of the sulfonamide class of antibiotics, which work by inhibiting the growth of bacteria by interfering with their ability to synthesize folic acid, an essential nutrient for bacterial growth. Sulfamethoxazole is typically used in combination with another antibiotic, such as trimethoprim, to increase its effectiveness and reduce the risk of resistance. It is usually taken orally in the form of tablets or capsules, and the dosage and duration of treatment will depend on the specific infection being treated and the patient's medical condition. It is important to note that sulfamethoxazole can cause side effects, including nausea, vomiting, diarrhea, headache, and allergic reactions. It may also interact with other medications, so it is important to inform your healthcare provider of all medications you are taking before starting treatment with sulfamethoxazole.

Fluorenes are a class of organic compounds that contain a benzene ring fused to a fluorine atom. They are typically colorless or yellowish solids with a characteristic odor. In the medical field, fluorenes have been studied for their potential use as drugs and as imaging agents. For example, some fluorenes have been shown to have anti-inflammatory and anti-cancer properties, while others have been used as fluorescent probes to visualize specific cellular processes. However, more research is needed to fully understand the potential therapeutic applications of fluorenes.

While occasionally used in pregnancy it is unclear if pyrimethamine is safe for the baby. Pyrimethamine is classified as a ... Sulfadoxine/pyrimethamine "Pyrimethamine (Daraprim) Use During Pregnancy". Drugs.com. 31 July 2019. Archived from the original ... Due to the emergence of pyrimethamine-resistant strains of P. falciparum, pyrimethamine alone is seldom used now. In ... Pyrimethamine has also been used in several trials to treat retinochoroiditis. Pyrimethamine is labeled as pregnancy category C ...
Pyrimethamine is on the World Health Organization's List of Essential Medicines, the most important medications needed in a ... As part of an academic extension activity, a group of year 11 students attempted to prepare the medication pyrimethamine (sold ... American Society of Health-System Pharmacists (8 February 2016). "Pyrimethamine". Drugs.com. Archived from the original on 2 ... have prepared pyrimethamine. The students started with 17 g of (4-chlorophenyl)acetonitrile (which is available from Sigma- ...
The team produced 3.7 grams of pyrimethamine for under US$20, which would be worth between $US35,000 and $US110,000 in the ... "Pyrimethamine". Drugs.com. 5 March 2019. Archived from the original on 26 April 2019. Retrieved 26 April 2019. Hamilton, ... Pyrimethamine is a pharmaceutical medicine used in combination with leucovorin to treat toxoplasmosis and cystoisosporiasis and ... In 2015, Turing Pharmaceuticals drastically increased the price of pyrimethamine, which it markets as Daraprim, from about US$ ...
pyrimethamine (Daraprim), for malaria. trimethoprim (Septra), for meningitis, sepsis, and bacterial infections of the urinary ...
Pyrimethamine (Daraprim), for malaria. Trimethoprim (Proloprim, Monoprim, others), for meningitis, sepsis, and bacterial ...
Daraprim is the trade name for the drug pyrimethamine, which is indicated for the treatment of toxoplasmosis in combination ... The company has two marketed products: Daraprim (pyrimethamine), for the treatment of toxoplasmosis, and Vecamyl (mecamylamine ... "Turing Reduces Cost of Daraprim® (pyrimethamine)". Turingpharma.com. November 24, 2015. Archived from the original on 22 ... "Turing Pharmaceuticals AG Acquires U.S. Marketing Rights to DARAPRIM® (pyrimethamine)". Turingpharma.com. August 10, 2015. ...
It is also used in the production of some antimalarial drugs including pyrimethamine. Ethyl propionate can be synthesized by ... MacDonald, Thomas (29 January 2016). "Pyrimethamine synthesis: Status at end of 2015". Daraprim Synthesis. Open Source Malaria ...
"ReBalance® sulfadiazine/pyrimethamine oral suspension for horses". Prnpharmacal.com. Archived from the original on 2016-08-20. ... Currently, three FDA approved treatments are available in the US: ReBalance (sulfadiazine and pyrimethamine), Marquis ( ...
Combination with sulfadoxine=pyrimethamine is not recommended. The drug should be given in doses between 25 mg/kg and 35 mg/kg ... Pyrimethamine is used in the treatment of uncomplicated malaria. It is particularly useful in cases of chloroquine-resistant P ... Chloroquine/proguanil or sulfa drug-pyrimethamine combinations should be used in all other plasmodia infections. The major ... Artemisinin-based combination therapies should be used in preference to amodiaquine plus sulfadoxine-pyrimethamine for the ...
Fansidar (sulfadoxine/pyrimethamine), for malaria and toxoplasmosis. Fuzeon (enfuvirtide), for salvage therapy of HIV-1 ...
Pyrimethamine is a widely used antiprotozoal agent. Other classes of compounds that target DHFR in general, and bacterial DHFRs ...
Sulfadoxine-pyrimethamine (SP) is administered to pregnant women. Two to three doses of SP has been proven to reduce the levels ... Sulfadoxine-pyrimethamine (SP) administration to pregnant women is also a source of prevention in order to reduce the risks of ... "Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk ...
The presence of pyrimethamine proved to be toxic. Tests done at the Central Drugs Laboratory in Karachi also verified the ... "Isotab Contamination with pyrimethamine issu: FIA seals three firms manufacturing deadly Isotab - PakMed Info Forum". Pakmed. ... The report also showed that Isotab contained pyrimethamine which is in fact used for the treatment of malaria. ... and identified the factory of Efroze Chemicals in Karachi as the producer of the Isotab tablets contaminated with pyrimethamine ...
It is also used in combination with sulfadoxine/pyrimethamine. There have been reports of increased liver toxicity in people ... Seasonal malaria chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine in children: a field guide (PDF). Geneva: The ... World Health Organization (2013). Seasonal malaria chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine in children ... sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a ...
"Biodegradable long circulating cellular carrier for antimalarial drug pyrimethamine". Artificial Cells, Nanomedicine, and ...
"Daraprim (pyrimethamine) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Retrieved 12 ... Some such as proguanil, pyrimethamine and trimethoprim selectively inhibit folate's actions in microbial organisms such as ...
In-feed pyrimethamine and sulfadimethoxine can help prevent the disease. Prevention is by control of the infecting vectors but ...
If the fetus has been infected, the pregnant woman can be treated with pyrimethamine and sulfadiazine, with folinic acid, after ... They are treated after the first trimester because pyrimethamine has an antifolate effect, and lack of folic acid can interfere ... During pregnancy, spiramycin or pyrimethamine/sulfadiazine and folinic acid may be used for treatment. Up to half of the ... The medications prescribed for acute toxoplasmosis are the following:[citation needed] Pyrimethamine - an antimalarial ...
After widespread pyrimethamine resistance was reported, pyrimethamine was replaced by chloroquine. From 1961 to 1962, 75 tons ... Salt crystals were mixed with pyrimethamine so as to provide a 0.07% pyrimethamine salt. As there were no shops in the ... The target population of 83,000 received a single dose of pyrimethamine at the beginning of the malaria season in 1953 and 1954 ... In addition, in 60 villages, MDA with sulfalene / pyrimethamine was given at 10-week intervals for two years. In two small ...
doi:10.1016/0035-9203(63)90019-1. Morley, David (14 March 1964). "Controlled Trial of Pyrimethamine in Pregnant Women in an ...
Amodiaquine plus sulfadoxine-pyrimethamine may achieve less treatment failures when compared to sulfadoxine-pyrimethamine alone ... Sulfadoxine-pyrimethamine plus artesunate is better than sulfadoxine-pyrimethamine plus amodiaquine in controlling treatment ... Cochrane Infectious Diseases Group) (January 2006). "Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine ... Giving sulfadoxine-pyrimethamine for three or more doses as intermittent preventive therapy is superior than two doses for HIV- ...
... /pyrimethamine Scholia has a topic profile for Sulfadoxine. Medical Treatment - Sulphadoxine and Pyrimethamine ... It is also used to prevent malaria but due to high levels of sulphadoxine-pyrimethamine resistance, this use has become less ... Sulfadoxine (also spelled sulphadoxine) is an ultra-long-lasting sulfonamide used in combination with pyrimethamine to treat ... 2014). "High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six ...
During treatment with pyrimethamine, leukocyte and platelet counts should be monitored weekly. Folinic acid protects against ... When vision is affected or threatened, treatment consists of pyrimethamine, sulfadiazine, and folinic acid for 4-6 weeks. ... Sight-threatening lesions are treated for 4-6 weeks with triple therapy consisting of pyrimethamine, sulfadiazine, and folinic ... the decrease in platelets and white blood cells induced by pyrimethamine. Prednisone may be used for 3-6 weeks to reduce ...
Chloroquine Doxycycline Mefloquine Proguanil Sulfadoxine/pyrimethamine (sulfadoxine + pyrimethamine) Pyrimethamine Sulfadiazine ... Doxycycline Mefloquine Primaquine Quinine Sulfadoxine/pyrimethamine (sulfadoxine + pyrimethamine) Amodiaquine + sulfadoxine/ ... To be used in combination with either amodiaquine, mefloquine, or sulfadoxine + pyrimethamine. Other combinations that deliver ...
Chloroquine Doxycycline Mefloquine Proguanil Sulfadoxine/pyrimethamine (sulfadoxine + pyrimethamine) Pyrimethamine Sulfadiazine ... Doxycycline Mefloquine Primaquine Quinine Sulfadoxine/pyrimethamine (sulfadoxine + pyrimethamine) Amodiaquine + sulfadoxine/ ... To be used in combination with either amodiaquine, mefloquine or sulfadoxine + pyrimethamine. Other combinations that deliver ...
The drug pyrimethamine has been shown to increase activity of β-hexosaminidase A. However, the increased levels of β- ... "Pyrimethamine increases β-hexosaminidase A activity in patients with Late Onset Tay Sachs". Mol. Genet. Metab. 102 (3): 356-63 ...
The use of highly active antiretroviral therapy (HAART), in conjunction with the established pyrimethamine-based maintenance ... Pyrimethamine-based maintenance therapy is often used to treat toxoplasmic encephalitis (TE), which is caused by Toxoplasma ... "Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis". Pathogens and ...
"Crystal structure of β-hexosaminidase B in complex with pyrimethamine, a potential pharmacological chaperone". Journal of ...
... pyrimethamine) are more charged inside the cell than outside. The cell membrane is permeable to non-ionized (fat-soluble) ...
Weber MC, de Clarke V, Harwin RM, Shiff CJ (September 1975). "An extended field trial of pyrimethamine combined with dapsone in ...
This was the case with Pyrimethamine (sold as Daraprim), which is used to treat toxoplasmosis and malaria, among other users. ...
Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, ... Nationwide Monitoring for Plasmodium falciparum Drug-Resistance Alleles to Chloroquine, Sulfadoxine, and Pyrimethamine, Haiti, ...
MA178 - Pyrimethamine/Sulfadoxine - 12.5mg/250mg - Dispersible tablet - Guilin Pharmaceutical Co., Ltd - CHINA. ... MA179 - Pyrimethamine/Sulfadoxine - 25mg/500mg - Dispersible tablet - Guilin Pharmaceutical Co., Ltd - CHINA ...
Surveillance for sulfadoxine-pyrimethamine resistant malaria parasites in the Lake and Southern Zones, Tanzania, using pooling ... Surveillance for sulfadoxine-pyrimethamine resistant malaria parasites in the Lake and Southern Zones, Tanzania, using pooling ... Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) is recommended to prevent the adverse ... Surveillance for sulfadoxine-pyrimethamine resistant malaria parasites in the Lake and Southern Zones, Tanzania, using pooling ...
Text; Format: print Publication details: Geneva : World Health Organization 2008Other title: Technical expert group meeting on intermittent preventive treatment in pregnancy (IPTp), Geneva, 11-13 July 2007..Online access: Click here to access online Availability: Items available for loan: WHO HQ (1)Call number: WC 765 2008TE. ...
Pyrimethamine. What the FTC wants from Martin Shkreli and his company Druglike. 06/05/2023. 12/25/2022. by spaceptc ... Pyrimethamine, Quartz, Shkreli, Turing Pharmaceuticals, Wu-Tang clan Leave a comment. ...
Sulfadoxine-pyrimethamine: A drug used against malaria. Its value has been compromised by the emergence of drug-resistant ... Fansidar: Brand name of sulfadoxine-pyrimethamine, a drug used against malaria. Its value has been compromised by the emergence ...
... pyrimethamine (Daraprim); and tricyclic antidepressants (mood elevators) such as amitriptyline (Elavil), amoxapine (Asendin), ...
Quadruple therapy refers to pyrimethamine, sulfadiazine, clindamycin, and prednisone (1 mg/kg of weight). Pyrimethamine should ... Azithromycin - 250 mg/d or 500 mg every other day in combination with pyrimethamine 100 mg on the first day followed by 50 mg/d ... Spiramycin, pyrimethamine, and folinic acid may be used during the third trimester. [32] ... Triple drug therapy refers to pyrimethamine (loading dose of 75-100 mg during the first day, followed by 25-50 mg on subsequent ...
Plasmodium falciparum resistance to intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) continues to ... resistance mutations to sulfadoxine-pyrimethamine, transmission intensity and risk of malaria infection in pregnancy in Mount ...
The antifolate sulphadoxine-pyrimethamine (SP) has been used in the intermittent prevention of malaria in pregnancy (IPTp). SP ... Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at ... "Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at ... "Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at ...
Dapsone, dapsone with pyrimethamine, dapsone with trimethoprim, and sulfadoxine with pyrimethamine have been used in various ... oral pyrimethamine plus dapsone; oral pyrimethamine-sulfadoxine; oral clindamycin plus primaquine; oral quinolone; and oral ... Weekly dapsone and dapsone/pyrimethamine for pneumocystis pneumonia prophylaxis. (Abstract WB2207). VII International ... and a trial assessing once weekly dapsone-pyrimethamine for secondary prophylaxis is under way in Europe. Intermittent ...
CNS Toxoplasmosis, With Pyrimethamine or Leucovorin (Off-label). 600 mg IV or PO q6hr for at least 6 weeks ...
Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar Share ... Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar ...
The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub- ... The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub- ...
pyrimethamine *quinine *quinolone antibiotics (e.g., ciprofloxacin, norfloxacin, ofloxacin). *rifampin. *rivaroxaban. * ...
Toxoplasmosis as adjunctive therapy with pyrimethamine. Malaria due to chloroquine-resistant strains of Plasmodium falciparum, ... with pyrimethamine); pregnant women at term; and mothers nursing infants less than 2 months of age. ...
Intercontinental spread of pyrimethamine-resistant malaria. Science 305 :1124.. Roper C, Pearce R, Nair S, Sharp B, Nosten F, ... Intercontinental spread of pyrimethamine-resistant malaria. Science 305 :1124.. Roper C, Pearce R, Nair S, Sharp B, Nosten F, ... Treatment failure of pyrimethamine-sulphadoxine and induction of Plasmodium falciparum gametocytaemia in children in western ... Treatment failure of pyrimethamine-sulphadoxine and induction of Plasmodium falciparum gametocytaemia in children in western ...
artesunate, sulphamethopyrazine and pyrimethamine. artesunate, sulfalene and pyrimethamine. DDD alterations. ATC code. ATC ...
pyrimethamine. Minor (1)dapsone, pyrimethamine. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Increased ... pyrimethamine. dapsone, pyrimethamine. Mechanism: pharmacodynamic synergism. Minor/Significance Unknown. Increased bone marrow ... 50 mg qDay in combination with weekly pyrimethamine and leucovorin. Treatment. *100 mg PO qDay in combination with trimethoprim ... Adolescents: 100 mg PO qDay or divided BID as monotherapy, OR 50 mg qDay in combination with weekly pyrimethamine and ...
Primaquine Clears Submicroscopic Plasmodium falciparum Gametocytes that Persist after Treatment with Sulphadoxine-Pyrimethamine ...
... pyrimethamine [and leucovorin] in conjunction with sulfadiazine) cannot be used; used in conjunction with pyrimethamine (and ... dapsone in conjunction with pyrimethamine [and leucovorin]) cannot be used; used alone or in conjunction with pyrimethamine ( ... sulfadiazine in conjunction with pyrimethamine [and leucovorin]) and recommended alternative (pyrimethamine [and leucovorin] in ... Adolescents ≥13 years of age: 1.5 g once daily. Alternatively, 1.5 g once daily in conjunction with oral pyrimethamine (25 mg ...
Therefore, treatment is begun with oral pyrimethamine (initial loading dose of 2 mg/kg once a day for 2 days followed by 1 mg/ ... After the initial 6 months of treatment, sulfadiazine and leucovorin are continued at the same dose, but pyrimethamine is given ... Pyrimethamine and sulfonamides have been used later in gestation to treat the infected fetus. ...
certain medicines (such as phenytoin [Dilantin], methotrexate, sulfasalazine, triamterene, pyrimethamine, trimethoprim- ...
Antiparasitic therapy, using pyrimethamine and sulfadiazine, and serial neuroimaging often enable clinicians to differentiate ...
  • Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) is recommended to prevent the adverse consequences of MiP. (rti.org)
  • Sub-microscopic Plasmodium falciparum parasitaemia, dihydropteroate synthase (dhps) resistance mutations to sulfadoxine-pyrimethamine, transmission intensity and risk of malaria infection in pregnancy in Mount Cameroon Region. (bvsalud.org)
  • Plasmodium falciparum resistance to intermittent preventive treatment with sulfadoxine - pyrimethamine (IPTp-SP) continues to spread throughout sub-Saharan Africa . (bvsalud.org)
  • The approach has led to a dramatic increase in pregnant women receiving a third dose of intermittent preventive treatment (IPTp3) using sulfadoxine-pyrimethamine, as recommended by the World Health Organization. (jhpiego.org)
  • Chloroquine, quinine and sulfadoxine/pyrimethamine were the most available and prescribed antimalarial drugs in all 60 pharmacies (government and private) in the city. (who.int)
  • andthatarerelatedtolocalvariables differentpharmacologicalformulations Sulfadoxine/pyrimethamine,halofan- inourcountry[ 2 ].Therearecertain andstrengthsofantimalarialdrugs.This trineandartemetherwereprescribed prescribingpatternsthatmighthave wasdonebydirectinterviewwiththe in 4.8%, 2.4% and 2.4% of prescrip- directinfluenceontheeffectiveness pharmacistsandtheirassistants. (who.int)
  • Development of resistance to inexpensive treatment drugs such as chloroquine in the 1950s and 1960s and sulphadoxine-pyrimethamine in the 1970s led to the reversal of decades worth of gains achieved by malaria control programs. (cdc.gov)
  • used alone or in conjunction with pyrimethamine (and leucovorin) for primary PCP prophylaxis in HIV-infected adults and adolescents. (drugs.com)
  • pyrimethamine (and leucovorin) in conjunction with clindamycin is preferred alternative in those who cannot tolerate or do not respond to regimen of choice. (drugs.com)
  • Atovaquone in conjunction with pyrimethamine (and leucovorin), atovaquone in conjunction with sulfadiazine, or atovaquone alone are alternative regimens for treatment of toxoplasmosis † [off-label] in HIV-infected adults and adolescents when regimen of choice and preferred alternative cannot be used. (drugs.com)
  • The purpose of this study is to determine the comparative efficacy of artesunate plus sulfamethoxypyrazine-pyrimethamine versus Praziquantel in the treatment of school children infected with S.mansoni in western Kenya. (drugpatentwatch.com)
  • Our product range includes a wide range of zestril lisinopril tablets, artesunate pyrimethamine sulfadoxine combikit, primaquine phosphate 7.5 mg, hcqs 400 tablet hydroxychloroquine tablet, quinine sulphate 300 mg and premaquine 7.5 mg tablets. (onlinepharmacysolution.com)
  • This was the case with Pyrimethamine (sold as Daraprim), which is used to treat toxoplasmosis and malaria, among other users. (hackaday.com)
  • Pyrimethamine, more commonly known as Daraprim, is a drug that is frequently prescribed for the treatment of protozoal infections and malaria around the world. (brown.edu)
  • Combination product containing sulfadoxine 500 mg and 25 mg pyrimethamine. (medscape.com)
  • Results of search for 'su:{Pyrimethamine. (who.int)
  • Pyrimethamine therapy, perhaps shortened, may rapidly decrease size of spleen. (medscape.com)
  • Efficacy of mefloquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum infection in Machinga District, Malawi, 1998. (ajtmh.org)
  • High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. (ajtmh.org)
  • Assessing the efficacy of chloroquine and sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in the Democratic Republic of Congo. (ajtmh.org)
  • In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment. (ajtmh.org)
  • Severe cutaneous adverse reactions to sulfadoxine-pyrimethamine in Switzerland. (nih.gov)
  • Serious reactions during malaria prophylaxis with pyrimethamine-sulfadoxine. (nih.gov)
  • Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment. (nih.gov)
  • The risks of pyrimethamine-sulfadoxine combination in the prenatal treatment of toxoplasmosis]. (nih.gov)
  • The combination of sulfadoxine and pyrimethamine is used in the treatment and prophylaxis of chloroquine resistant strains of malaria and the treatment of toxoplasmosis. (nih.gov)
  • Sulfadoxine-pyrimethamine has been linked with rare cases of idiosyncratic liver injury which resembles the hepatotoxicity associated with sulfonamides. (nih.gov)
  • Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand. (nih.gov)
  • Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii. (nih.gov)
  • Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine: More than Just an Antimalarial? (cdc.gov)
  • For monitoring efficacy of sulfadoxine/pyrimethamine intermittent preventive treatment for malaria during pregnancy, data obtained from studies of children seemed inadequate. (cdc.gov)
  • High prevalence of triple and quadruple mutants in the dihydropteroate synthase and dihydrofolate reductase genes of Plasmodium falciparum parasites contrasts with the efficacy of sulfadoxine/pyrimethamine in reducing low birthweights and placental infection rates. (cdc.gov)
  • Until recently, prevention consisted of weekly chemoprophylaxis with either chloroquine or sulfadoxine/pyrimethamine. (cdc.gov)
  • Because of poor patient compliance with prophylaxis and increasing resistance of parasite strains to chloroquine, administration of intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine/pyrimethamine is now recommended for all pregnant women living in areas with stable malaria transmission ( 3 ). (cdc.gov)
  • Administration of three courses of sulfadoxine/pyrimethamine (SP) as intermittent preventive treatment (IPTi) to infants when they receive EPI vaccines reduced the incidence of malaria and anaemia in infants in an area with low SP resistance, low transmission pressure and high bednet use. (druglib.com)
  • C - Risk of P. falciparum malaria, in combination with reported chloroquine and sulfadoxine-pyrimethamine resistance. (tripprep.com)
  • Sulfadoxine-pyrimethamine has been widely used as first-line therapy for uncomplicated malaria throughout sub-Saharan Africa. (elsevierpure.com)
  • Dispersible sulfadoxine-pyrimethamine and amodiaquine and matching placebos ended up donated by Guilin Pharmaceutical. (besthealthideas.com)
  • Small children in the chemoprevention-by yourself group and the mixture team acquired four courses of sulfadoxine-pyrimethamine and amodiaquine at every month intervals each yr small children in the vaccine-by yourself group gained four courses of sulfadoxine-pyrimethamine and amodiaquine placebos on that very same plan. (besthealthideas.com)
  • Administration of each dose of sulfadoxine-pyrimethamine and amodiaquine or placebo was specifically noticed by demo staff at distribution factors in trial villages. (besthealthideas.com)
  • The US Food and Drug Administration (FDA) has approved the first generic version of the antiparasitic drug Daraprim (pyrimethamine) for the treatment of toxoplasmosis when used with a sulfonamide. (medscape.com)
  • Cite this: FDA OKs First Generic of Daraprim (Pyrimethamine) Tablets - Medscape - Mar 02, 2020. (medscape.com)
  • Pyrimethamine (Daraprim) Pyrimethamine is used to treat parasite infections. (nih.gov)
  • Folic acid might decrease the effectiveness of pyrimethamine (Daraprim) for treating parasite infections. (nutrawiki.org)
  • Use of pyrimethamine is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. (nih.gov)
  • Pyrimethamine is contraindicated in patients with known hypersensitivity to pyrimethamine or with documented megaloblastic anemia due to folate deficiency. (medscape.com)
  • Pyrimethamine is a folic acid antagonist and the rationale for its therapeutic action is based on the differential requirement between host and parasite for nucleic acid precursors involved in growth. (nih.gov)
  • dihydropteroate synthase (sulphadoxine) and dihydrofolate reductase (pyrimethamine) both of which are involved in the production of folic acid in the parasite cells. (com.ng)
  • Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria. (ajtmh.org)
  • Studies on Genetic Mutations in Plasmodium Falciparum Strains Associated With 4- Aminoquinolines (Chloroquine) and Pyrimethamine Sulphadoxine (Fansidar) Resistance in Ghanaian Malaria Patients. (edu.gh)
  • Pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. (nih.gov)
  • The dosage of pyrimethamine required for the treatment of toxoplasmosis has a narrow therapeutic window. (nih.gov)
  • a 51-year-old female who developed chronic granulocytic leukemia after taking pyrimethamine for 2 years for toxoplasmosis 3 and a 56-year-old patient who developed reticulum cell sarcoma after 14 months of pyrimethamine for toxoplasmosis. (nih.gov)
  • A small "starting" dose for toxoplasmosis is recommended in patients with convulsive disorders to avoid the potential nervous system toxicity of pyrimethamine. (nih.gov)
  • With doses of pyrimethamine used to treat toxoplasmosis, anorexia and vomiting may also occur. (medscape.com)
  • of infants with congenital toxoplasmosis most often includes pyrimethamine , sulfadiazine, and leucovorin for one year. (nih.gov)
  • As an alternative to sulfonamides, clindamycin may be beneficial when used with pyrimethamine in acute treatment of CNS toxoplasmosis in patients with AIDS. (medscape.com)
  • Pyrimethamine and sulfadiazine are synergistic against Toxoplasma species. (medscape.com)
  • It is also used in patients who are unable to tolerate pyrimethamine and sulfadiazine due to side effects. (medscape.com)
  • Women of childbearing potential who are taking pyrimethamine should be warned against becoming pregnant. (nih.gov)
  • Genetic Toxicity Evaluation of Pyrimethamine in Salmonella/E.coli Mutagenicity Test or Ames Test. (nih.gov)
  • Pyrimethamine has been reported to produce a significant increase in the number of lung tumors in mice when given intraperitoneally at doses of 25 mg/kg. (nih.gov)
  • Patients should also be warned that the appearance of sore throat, pallor, purpura, or glossitis may be early indications of serious disorders which require treatment with pyrimethamine to be stopped and medical treatment to be sought. (nih.gov)
  • Pyrimethamine should be kept out of the reach of infants and children as they are extremely susceptible to adverse effects from an overdose. (nih.gov)
  • Pyrimethamine is an antiparasitic compound available in tablet form for oral administration. (nih.gov)
  • Pyrimethamine should be used with caution in patients with impaired renal or hepatic function or in patients with possible folate deficiency, such as individuals with malabsorption syndrome, alcoholism, or pregnancy, and those receiving therapy, such as phenytoin, affecting folate levels (see Pregnancy subsection). (nih.gov)
  • The action of pyrimethamine against Toxoplasma gondii is greatly enhanced when used in conjunction with sulfonamides. (nih.gov)
  • Pancytopenia in a patient given pyrimethamine and sulphamethoxidiazine during pregnancy. (nih.gov)
  • Patients should be warned that at the first appearance of a skin rash they should stop use of pyrimethamine and seek medical attention immediately. (nih.gov)
  • Patients should be warned to keep pyrimethamine out of the reach of children. (nih.gov)
  • Pyrimethamine is well absorbed with peak levels occurring between 2 to 6 hours following administration. (nih.gov)
  • pyrimethamine increases levels of eliglustat by affecting hepatic enzyme CYP2D6 metabolism. (medscape.com)
  • Pyrimethamine should be stored out of the reach of children, the FDA advises. (medscape.com)
  • pyrimethamine will increase the level or effect of erdafitinib by affecting hepatic enzyme CYP2C9/10 metabolism. (medscape.com)
  • Pyrimethamine is 87% bound to human plasma proteins. (nih.gov)